
Keywords: ACSF; artificial cerebrospinal fluid; AMPAR; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; AP5; d-(â)-2-amino-5-phosphonopentanoic acid; DAAO; d-amino acid oxidase; DCKA; 5,7-dichlorokynurenic acid; EGTA; ethylene glycol tetraacetic ac